Jun 01, 2019 / Chapters Executive summary (June 2019 report) Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Apr 30, 2019 / Congressional Testimony Testimony: Payment Policy for Prescription Drugs Under Medicare Part B and Part D (Energy and Commerce) Research Areas: Drugs, Devices, and Tests
Apr 05, 2019 / Presentations Options to increase the affordability of specialty drugs and biologics in Medicare Part D Research Areas: Drugs, Devices, and Tests, Private Plans
Apr 05, 2019 / Comment Letters MedPAC comment on OIG’s proposed rule on safe harbor regulation of prescription drug rebates Research Areas: Delivery System Reforms, Drugs, Devices, and Tests, Medicare Spending and Financing
Mar 15, 2019 / Reports March 2019 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Mar 15, 2019 / Fact Sheets Fact sheet on MedPAC’s March 2019 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Mar 15, 2019 / Press Releases MedPAC releases March 2019 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Mar 01, 2019 / Chapters Chapter 14: The Medicare prescription drug program (Part D): Status report (March 2019 report) Research Areas: Drugs, Devices, and Tests
Mar 01, 2019 / Chapters Chapter 16: Mandated report: Opioids and alternatives in hospital settings—Payments, incentives, and Medicare data (March 2019 report) Research Areas: Drugs, Devices, and Tests, Hospitals
Mar 01, 2019 / Chapters Executive summary (March 2019 report) Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues